MHRA drug safety update

The Medicines and Healthcare-products Regulatory Agency (MHRA) has issued a drug safety update covering restrictions on use of daclizumab (Zinbryta), which may cause liver injury; advice on prescribing co-dydramol; and reporting procedure for suspected adverse reactions to herbal medicines.
Source: NHS Networks - Category: UK Health Source Type: news